Loading...
Biliary tract cancer: implicated immune-mediated pathways and their associated potential targets.
Tariq, Noor-Ul-Ain Vogel, A
Tariq, Noor-Ul-Ain
Vogel, A
Citations
Altmetric:
Abstract
There is a well-established link between biliary tract cancers (BTC) and chronic inflammatory conditions such as primary sclerosing cholangitis, chronic cholecystitis, chronic cholelithiasis, liver fluke-associated infestations, and chronic viral hepatic infections. These associated risk factors highlight the potential for development of immune-modulatory agents in this poor-prognostic disease group with limited treatment options. Clinical trials have evaluated the role of immune cells, inflammatory biomarkers, vaccines, cytokines, adoptive cell therapy, and immune checkpoint inhibitors in patients with BTC. Although these have demonstrated the importance of the immune environment in BTC, currently none of the immune-based therapies have been approved for use in this disease group. The role of immunomodulatory agents is a developing field and has yet to find its way 'from bench to bedside' in BTC.
Affiliation
Description
Date
2018
Publisher
Collections
Files
Loading...
author manuscript
Microsoft Word XML, 88 KB
Keywords
Type
Article
Citation
Biliary tract cancer: implicated immune-mediated pathways and their associated potential targets. 2018, 41(5): 298-304 Oncol Res Treat